Ibrutinib and Rituximab in Waldenström's Macroglobulinemia

Affiliations

¹ National and Kapodistrian University of Athens School of Medicine, Athens, Greece mdimop@med.uoa.gr
² Pharmacyclics, Sunnyvale, CA
³ University Hospital of Ulm, Ulm, Germany

Comment

Meletios A Dimopoulos et al. N Engl J Med. 2018.

. 2018 Nov 15;379(20):1975-1976.

doi: 10.1056/NEJMc1809505.

¹ National and Kapodistrian University of Athens School of Medicine, Athens, Greece mdimop@med.uoa.gr
² Pharmacyclics, Sunnyvale, CA
³ University Hospital of Ulm, Ulm, Germany

No abstract available

Comment on

Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.
Olszewski AJ, Castillo JJ. Olszewski AJ, et al. N Engl J Med. 2018 Nov 15;379(20):1973-4. doi: 10.1056/NEJMc1809505. N Engl J Med. 2018. PMID: 30439672 No abstract available.
Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.
Cavazzini F, Rigolin GM, Cuneo A. Cavazzini F, et al. N Engl J Med. 2018 Nov 15;379(20):1974-5. doi: 10.1056/NEJMc1809505. N Engl J Med. 2018. PMID: 30440049 No abstract available.